证券代码：603210 证券简称：泰鸿万立 公告编号：2025-011 浙江泰鸿万立科技股份有限公司关于子公司开立募集资金专项账户 并签订募集资金专户存储四方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金的基本情况 经中国证券监督管理委员会《关于同意浙江泰鸿万立科技股份有限公司首次公开发行股票注册的批复》 （证监许可〔2024〕1660号）同意注册，并经上海证券交易所同意，公司首次公开发行人民币普通股 （A股）8,510.00万股，发行价格为8.60元/股，本次发行募集资金总额为73,186.00万元，扣除发行费用 10,307.69万元（不含增值税）后，募集资金净额为62,878.31万元。上述募集资金已于2025年4月3日全部 到位。容诚会计师事务所（特殊普通合伙）对本次募集资金到位情况进行了审验，并出具了《验资报 告》（容诚验字[2025]230Z0027号）。公司已对上述募集资金进行专户存储管理，并与保荐机构、募集 资金专户开户银行签署《募集资金专户存储三方监管协议》。 二、本次《募集资金 ...

证券代码：688336 证券简称：三生国健 公告编号：2025-025 三生国健药业（上海）股份有限公司 关于将部分项目节余资金用于暂时补充流动资金以 及调整部分募投项目拟投入募集资金金额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●三生国健药业（上海）股份有限公司（以下简称"公司"或"三 生国健"）拟将"抗体药物生产新建项目"、"抗肿瘤抗体药物的新 药研发项目"、"研发中心建设项目"及"补充营运资金项目"节余 资金 6,662.82 万元暂时补充流动资金。 ●拟缩减"创新抗体药物产业化及数字化工厂建设项目"募集 资金承诺投资总额，由 40,000.00 万元调减为 32,000.00 万元，调减 金额为 8,000.00 万元；拟增加"自身免疫及眼科疾病抗体药物的新 药研发项目"募集资金承诺投资总额，由 61,000.00 万元调增为 ●公司于 2025 年 5 月 26 日召开第五届董事会第八次会议和第五 届监事会第五次会议，审议通过了《关于将部分项目节余资金用于暂 时补充流动资金以及调整部 ...

国金证券股份有限公司（以下简称"保荐机构"）为立达信物联科技股份有 限公司（以下简称"立达信"或"公司"）首次公开发行股票并上市的保荐机构， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司章程指引》 《证券发行上市保荐业务管理办法》《上市公司监管指引第2号——上市公司募 集资金管理和使用的监管要求》《上海证券交易所股票上市规则》《上海证券交 易所上市公司自律监管指引第1号——规范运作》等有关规定，对立达信将部分 募投项目节余募集资金用于其他募投项目及部分募投项目延期的事项进行了核 查，核查情况如下： 一、募集资金基本情况 （一）实际募集资金金额及到位时间 经中国证券监督管理委员会《关于核准立达信物联科技股份有限公司首次公 开发行股票的批复》 （证监许可〔2021〕2186 号）核准，公司向社会公开发行人 民币普通股（A 股）5,000 万股，每股面值为人民币 1.00 元，发行价格为人民币 万元（不含增值税）后，实际募集资金净额为人民币 77,135.33 万元。 国金证券股份有限公司关于立达信物联科技股份有限公司 将部分募投项目节余募集资金用于其他募投项目及部分募投项 目延期的核查意见 前述 ...

Core Viewpoint - Tianyang New Materials (Shanghai) Technology Co., Ltd. has decided to terminate certain fundraising projects and postpone others due to changes in the real estate industry and overall market demand, aiming to maximize the efficiency of fund usage and protect investor interests [1][5][11]. Fundraising Overview - In 2020, the company raised approximately RMB 386.99 million through a private placement of 16,929,124 shares at RMB 22.86 per share [1]. - In 2022, the company raised approximately RMB 986.50 million by issuing 99,847,765 shares at RMB 9.88 per share, with a net amount of RMB 967.39 million after deducting issuance costs [2][3]. Fund Investment Projects - The 2020 fundraising was allocated to projects including high-end environmentally friendly wall fabrics, with a total investment of RMB 148 million, of which RMB 37.39 million was utilized by May 2025 [3][4]. - The 2022 fundraising was directed towards photovoltaic film projects, with a total investment of RMB 154.54 million, and RMB 96.74 million utilized by May 2025 [4]. Termination of Fundraising Projects - The "High-end Environmentally Friendly Wall Fabric Project" has reached 100% investment progress, with a total of RMB 18.55 million expected to be used. The project will be terminated due to insufficient market demand in the home decoration sector [5][6]. - The remaining funds from the terminated project will be permanently redirected to supplement working capital for daily operations [4][5]. Postponement of Fundraising Projects - The company plans to postpone the completion of the "Hot Melt Adhesive Materials Project" and the "Photovoltaic Film Projects" to June 2026 due to delays in construction progress and market conditions [8][9]. - Factors affecting the delay include increased competition in the hot melt adhesive market and low demand for photovoltaic components, which have impacted project timelines [9][10]. Impact of Project Changes - The termination of the "High-end Environmentally Friendly Wall Fabric Project" is not expected to adversely affect the company's normal operations, as existing production lines can meet current needs [6][10]. - The postponement of projects is a cautious decision based on objective reasons and does not alter the intended use of funds or harm shareholder interests [10][11]. Approval Process - The decisions regarding the termination and postponement of projects were approved in the board and supervisory meetings held on May 26, 2025, and will be submitted for shareholder approval [11][12].

Fundraising Overview - Panda Dairy Group Co., Ltd. has received approval from the China Securities Regulatory Commission for its initial public offering and has successfully raised funds [1][2] - The company has established a dedicated account for the raised funds and signed a tripartite supervision agreement with the bank and the sponsor [2][3] Fund Allocation - The company has decided to allocate 18 million yuan of the raised funds for a new project, specifically the "Ding'an Annual Production of 5,000 Tons of Food Raw Materials Project," with 10 million yuan earmarked for related tax fees and 8 million yuan for capital increase in Nanhang Pharmaceutical [2][3] - The name of Nanhang Pharmaceutical has been changed to Hainan Yeda Food Technology Co., Ltd. to align with development needs [2] Project Implementation - The company has approved Hainan Yeda as the implementing entity for the food raw materials project and has opened a dedicated fundraising account for this purpose [3][4] - The dedicated account is managed by China Construction Bank and is specifically for storing and using the funds related to the new project [3][4] Regulatory Compliance - The fundraising management is in accordance with relevant regulations and guidelines to protect the rights of minority investors [4][5] - The agreement stipulates that the funds must not be used for non-project purposes and outlines the responsibilities of all parties involved in the management and supervision of the funds [4][5][6] Monitoring and Reporting - The sponsor has the right to conduct on-site investigations and inquiries regarding the use of the funds, ensuring compliance with the established guidelines [5][6] - Any significant transactions or changes in the account must be reported to the sponsor within specified timeframes [6][7]

Core Points - The report provides an independent assurance conclusion on the use of previously raised funds by Ningbo Xingyuan Zhuomei Technology Co., Ltd. as of March 31, 2025, confirming compliance with regulatory guidelines [1][2][5] - The total amount raised from the initial public offering (IPO) was RMB 688 million, with a net amount of RMB 596.32 million after deducting related issuance costs, which was received in December 2022 [3][4] - The company has established a dedicated account for the raised funds and has implemented a management system to ensure the funds are used in a regulated, safe, efficient, and transparent manner [3][4] Fund Management - As of March 31, 2025, the balance of the raised funds was RMB 106.44 million, which includes RMB 39 million in cash management products and RMB 67.44 million in the dedicated account [4][7] - The company has utilized RMB 21.55 million of the raised funds in 2022 and has generated RMB 8.4 million in financial returns from the management of these funds [4][5] - The company has not made any changes to the actual investment projects funded by the raised capital as of the reporting date [4][5] Investment Projects - The company has committed to investing in projects such as high-strength magnesium alloy precision casting and has not reported any discrepancies between the actual investment amounts and the promised amounts [4][5] - The total actual investment in the projects funded by the raised capital was RMB 49.92 million, with no significant differences reported [4][5] - The company has also approved the use of excess raised funds for new projects, ensuring that the investment plans remain unaffected [5][6]

证券代码：300253 证券简称：卫宁健康 公告编号：2025-046 债券代码：123104 债券简称：卫宁转债 卫宁健康科技集团股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、募集资金到位情况 卫宁健康科技集团股份有限公司（以下简称"公司"）经中国证 券监督管理委员会《关于同意卫宁健康科技集团股份有限公司向不特 定对象发行可转换公司债券注册的批复》 （证监许可［2021］311 号） 核准，获准向不特定对象发行可转换公司债券 970.2650 万张，每张 面 值 为 人 民 币 100 元 ， 按 面 值 发 行 ， 募 集 资 金 总 额 为 人 民 币 实际募集资金净额为人民币 961,209,622.64 元。 容诚会计师事务所（特殊普通合伙）已对公司向不特定对象发行可转 换公司债券的募集资金到位情况进行了审验，并于 2021 年 3 月 23 日 出具了"容诚验字2021200Z0016 号" 下简称"国泰君安"）分别与宁波银行股份有限公司上海黄浦支行、 上海银行股份有限公司浦西支行（以下简称"上海银行浦西支行"） 中国民生银行股 ...

Fundraising Overview - The company Zhejiang Fulai New Materials Co., Ltd. has successfully completed its initial public offering (IPO) by issuing 30 million shares at a price of 20.43 RMB per share, raising a total of 612.9 million RMB, with a net amount of 530.63 million RMB after deducting issuance costs [1][2]. Fund Management and Regulatory Compliance - The company has signed a four-party supervision agreement for the storage of fundraising special accounts to ensure proper management of the raised funds and protect investor rights, in accordance with relevant laws and regulations [3][4]. - The agreement involves the company, its wholly-owned subsidiary Yantai Fulai New Materials Technology Co., Ltd., China Construction Bank, and CITIC Securities as the sponsor [4][5]. Fund Allocation and Usage - The special account will be exclusively used for the "New Materials Project" previously managed by the Yantai branch, which has now been transferred to the subsidiary [4][5]. - The company is authorized to invest a portion of the funds in cash management products, with strict regulations on the usage and management of these funds to ensure compliance with the Shanghai Stock Exchange guidelines [4][5]. Monitoring and Reporting - The sponsor (CITIC Securities) will conduct ongoing supervision of the fundraising management, including on-site inspections and inquiries, to ensure compliance with the agreement [5][6]. - Any expenditures from the special account must be reported to the sponsor within three working days, along with a detailed expenditure list [6][7].

Core Viewpoint - Shenzhen Huabao New Energy Co., Ltd. has approved changes to the use of part of the raised funds for the "Digital Zero Carbon Industrial Park Project" and established a special account for fund management [2][3][4]. Fundraising Overview - The company raised a total of RMB 5,828,645,675 through its initial public offering, with a net amount of RMB 5,594,596,404.45 after deducting issuance costs [2][3]. - The funds were fully received by September 13, 2022, and verified by Tianjian Accounting Firm [2]. Fund Management and Usage - A special account has been opened for the management of the funds, in compliance with regulatory requirements, to ensure investor protection [3][4]. - The company has signed a tripartite supervision agreement with China Construction Bank and its sponsor, Huatai United Securities, to oversee the fund's usage [5][6]. New Fundraising Special Account - The new special account is specifically designated for the Digital Zero Carbon Industrial Park Project, ensuring that funds are not used for other purposes [5][6]. - The agreement stipulates that any withdrawals exceeding RMB 50 million must be reported to the sponsor [6][7]. Profit Distribution Plan - The company plans to distribute cash dividends of RMB 11.50 per 10 shares and to increase capital by 4 shares for every 10 shares held, resulting in a total capital increase of 49,581,356 shares [12][14]. - The total number of shares after the distribution will increase from 124,800,000 to 174,381,356 [15]. Key Dates - The record date for the profit distribution is set for May 29, 2025, and the ex-dividend date is May 30, 2025 [16][18].

Group 1 - The company has announced the cancellation of its fundraising special account due to the completion of the "Zhejiang Shangyu Electronic Materials Base Project" and the full utilization of the raised excess funds [1][2] - The fundraising special account was opened by the company's wholly-owned subsidiary, Zhejiang Bayi Shikong Advanced Materials Co., Ltd., at China Construction Bank [1] - The company has completed the necessary procedures for the cancellation of the fundraising special account in accordance with relevant regulations [2]